pyrazines has been researched along with Chronic Insomnia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, T; Furumoto, A; Haku, T; Hidaka, M; Himeji, D; Ikeda, K; Ishida, M; Ishimaru, T; Kadowaki, N; Kakihana, Y; Kamikokuryo, C; Kaneko, M; Kawamura, M; Kurosu, T; Ohge, H; Saijo, M; Sakabe, S; Shimojima, M; Suemori, K; Takahashi, T; Takenaka, K; Taniguchi, T; Yamanaka, A; Yasukawa, M; Yoshikawa, T | 1 |
| Cheng, MS; Du, GJ; Ren, J; Sha, Y; Zhang, L | 1 |
| De Raeve, H; Lambert, J; Rombouts, S; Schroyens, W; Van de Velde, A; Van de Voorde, K; Van Regenmortel, N | 1 |
| Fedeli, S | 1 |
1 trial(s) available for pyrazines and Chronic Insomnia
| Article | Year |
|---|---|
[Controlled clinical study of a sleep-inducing drug, ethodroxizine].
Topics: Clinical Trials as Topic; Ethers; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Placebos; Pyrazines; Sleep Initiation and Maintenance Disorders | 1968 |
3 other study(ies) available for pyrazines and Chronic Insomnia
| Article | Year |
|---|---|
A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.
Topics: Adult; Aged; Aged, 80 and over; Amides; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Japan; Liver Diseases; Male; Middle Aged; Phlebovirus; Pyrazines; RNA, Viral; Severe Fever with Thrombocytopenia Syndrome; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Viral Load | 2021 |
Synthesis of RP 48497, an impurity of eszopiclone.
Topics: Azabicyclo Compounds; Chlorine; Cyclization; Eszopiclone; Hypnotics and Sedatives; Molecular Structure; Oxidation-Reduction; Piperazines; Pyrazines; Sleep Initiation and Maintenance Disorders | 2008 |
Bortezomib-induced Sweet's syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Administration Schedule; Erectile Dysfunction; Humans; Immunosuppressive Agents; Male; Melphalan; Methylprednisolone; Multiple Myeloma; Pain; Peripheral Nervous System Diseases; Prednisolone; Protease Inhibitors; Pyrazines; Recurrence; Sleep Initiation and Maintenance Disorders; Sweet Syndrome; Testicular Diseases | 2005 |